Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking method to diabetes management. These innovative therapies operate by mimicking the natural actions of GLP-1, a hormone released by the https://bookmarkwuzz.com/story20784853/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes